$12 Billion Worldwide Cell Therapy Industry to 2030 - Identify Growth Segments for Investment
07 juin 2022 06h03 HE | Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2022, Type, Therapy Type, Application" report has been added to ResearchAndMarkets.com's offering. This report...
GME_18x18.jpg
Global Plasma Pen Market Size & Trends - Forecast to 2026
06 déc. 2021 09h00 HE | Global Market Estimates
Brooklyn, New York, Dec. 06, 2021 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Plasma Pen Market is projected to grow at a CAGR...
22157.jpg
Global Cell Therapy Market Report 2021-2028 - Growing Adoption of Regenerative Medicine & Introduction of Novel Platforms and Technologies
22 oct. 2021 06h13 HE | Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Cell Therapy Market Size, Share & Trends Analysis Report by Use-type, by Therapy Type (Autologous, Allogenic), by Region (North America,...
22157.jpg
Global Cell Culture Protein Surface Coating Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
03 sept. 2021 07h28 HE | Research and Markets
Dublin, Sept. 03, 2021 (GLOBE NEWSWIRE) -- The "Cell Culture Protein Surface Coating Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
22157.jpg
Global Cell Therapy Market Report 2021 Featuring Fibrocell Science., JCR Pharma, PHARMICELL, Osiris, MEDIPOST, Vericel, Anterogen, Kolon TissueGene, Stemedica Cell Technologies, and AlloCure
30 juin 2021 04h33 HE | Research and Markets
Dublin, June 30, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global cell...
VBI-Vaccines-Vertical-Logo.png
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
20 déc. 2018 08h00 HE | VBI Vaccines, Inc.
CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...